Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-31

Clinical Trial Update: rHGH and Intestinal Permeability in Intestinal Failure [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating recombinant human growth hormone for intestinal permeability in short bowel syndrome; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Somatropin (somatropin)

Snippet

Sponsor: Northwestern University | Conditions: Short Bowel Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-03-31